Roivant Sciences Ltd (ROIV)
Days of sales outstanding (DSO)
Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | ||
---|---|---|---|---|---|---|
Receivables turnover | — | 1.51 | 1.63 | 8.21 | 1.72 | |
DSO | days | — | 242.21 | 224.22 | 44.44 | 212.17 |
March 31, 2025 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
Roivant Sciences Ltd's days of sales outstanding (DSO) has shown significant fluctuations over the years according to the data provided.
As of March 31, 2021, the company had a DSO of 212.17 days, indicating a relatively long period for the company to collect outstanding sales revenues.
By March 31, 2022, the DSO had decreased substantially to 44.44 days, reflecting an improvement in the efficiency of the company's accounts receivable management.
However, the DSO increased again to 224.22 days by March 31, 2023, and further to 242.21 days by March 31, 2024. These increases suggest a potential deterioration in the company's ability to collect payments from customers promptly.
Unfortunately, the data for March 31, 2025, is not available (indicated as "\u2014 days"), making it challenging to assess the current status of the company's DSO.
Overall, based on the available data, Roivant Sciences Ltd has experienced significant fluctuations in its DSO over the years, indicating varying efficiency in collecting outstanding sales revenues. The company may need to focus on improving its accounts receivable management to maintain a healthy cash flow cycle.
Peer comparison
Mar 31, 2025